Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
Published on: September 8, 2023
Diagnostic implication of fibrin degradation products and D-dimer in aortic dissection
Jian Dong1, Xianli Duan1, Rui Feng1
1Department of Vascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Insights
Fibrin degradation products (FDP) and D-dimer are elevated in aortic dissection patients. While not highly specific for differentiating from other cardiovascular diseases, they show diagnostic value against healthy controls.
Area of Science:
- Vascular Medicine
- Diagnostic Biomarkers
- Cardiovascular Diseases
Background:
- Fibrin degradation products (FDP) and D-dimer are implicated in vascular diseases.
- Their diagnostic utility in aortic dissection requires further clarification.
Purpose of the Study:
- To investigate the diagnostic value of FDP and D-dimer in patients with aortic dissection.
- To compare FDP and D-dimer levels in aortic dissection patients versus other cardiovascular conditions and healthy individuals.
Main Methods:
- Immune nephelometry was used to measure FDP and D-dimer levels.
- Logistic regression analysis assessed risk factors for aortic dissection.
- Receiver Operating Characteristic (ROC) curve analysis determined diagnostic accuracy.
Main Results:
- Aortic dissection patients exhibited significantly higher FDP and D-dimer levels compared to non-dissection patients and healthy controls.
- Both FDP and D-dimer were identified as risk factors for aortic dissection.
- ROC analysis indicated limited ability to distinguish aortic dissection from other cardiovascular diseases, but significant value (AUC 0.863) in differentiating from healthy controls.
Conclusions:
- Elevated FDP and D-dimer levels are associated with aortic dissection.
- FDP and D-dimer show potential as biomarkers for distinguishing aortic dissection from healthy states, but lack specificity for differentiating from other cardiovascular diseases.
Abstract:
Fibrin degradation products (FDP) and D-dimer have been considered to be involved in many vascular diseases. In this study we aimed to explore the diagnostic implication of FDP and D-dimer in aortic dissection patients. 202 aortic dissection patients were collected as the case group, 150 patients with other cardiovascular diseases, including myocardial infarction (MI, n = 45), pulmonary infarction (n = 51) and abdominal aortic aneurysm (n = 54) were collected as non-dissection group, and 27 healthy people were in the blank control group. The FDP and D-dimer levels were detected with immune nephelometry. Logist regression analysis was performed to evaluate the influence of FDP and D-dimer for the aortic dissection patients. ROC curve was used to determine the diagnostic value of FDP and D-dimer. The FDP and D-dimer levels were significantly higher in aortic dissection patients than in non-dissection patients and the healthy controls. FDP and D-dimer were both the risk factors for patients with aortic dissection. From the ROC analysis, diagnostic value of FDP and D-dimer were not high to distinguish aortic dissection patients from the non-dissection patients. However FDP and D-dimer could be valuable diagnostic marker to differentiate aortic dissection patients and healthy controls with both AUC 0.863.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Anticoagulant Drugs: Low-Molecular-Weight Heparins

